# GUARDANT HEALTH, INC. (GH) · Edgar & Edgarette company card

> Guardant Health (GH) grew revenue 32.9% in FY2025 to $982 million, operating margin -44.5% against a -12.4% median for medical laboratories, equity -4.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1576280 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/GH) · [JSON](https://www.pops4.com/boards/company/GH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $982M |
| Revenue growth, 1 year | 32.9% |
| Revenue growth per year | 27.3% |
| Operating margin | -44.5% (prior year -60.0%) |
| Net margin | -42.4% |
| Operating cash flow | −$185M |
| Capital spending | $48M |
| Free cash flow | −$233M |
| Cash | $378M |
| Long-term debt | $1.5B |
| Total assets | $2.0B |
| Total equity | −$99M |
| Equity ÷ assets | -4.9% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -2.57 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -2.78 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative; operating loss: a margin of -44.5% in FY2025
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $982.0M (FY2025), total debt $1.5B. Experience: revenue up 32.9% on the year, up 27.3% a year over 4 years; operating margin -44.5%, up from -60.0%. Soundness: equity -4.9% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.1B and $1.4B next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1.0B to $1.5B. A statistical range, not company guidance. Against peers (17 filers, $50M+ revenue, services-medical laboratories): operating margin -44.5% against a -12.4% median; growth 32.9% against 13.8%.

Range logged 2026-10-31, receipt fd1c88c8e0a0ff52, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-11-03 ([filing](https://www.sec.gov/Archives/edgar/data/1576280/000119312526445514/0001193125-26-445514-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1576280/000119312526445514/0001193125-26-445514-index.htm)
- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1576280/000119312526444416/0001193125-26-444416-index.htm)
- 10-Q · filed 2026-07-30 · [filing](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000037/0001576280-26-000037-index.htm)
- 8-K · filed 2026-07-30 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000036/0001576280-26-000036-index.htm)
- 8-K · filed 2026-06-18 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1576280/000119312526275864/0001193125-26-275864-index.htm)
- 10-Q · filed 2026-05-07 · [filing](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000026/0001576280-26-000026-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001576280.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1576280

## Cite

POPS4, Edgar & Edgarette: GUARDANT HEALTH, INC. (GH) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/GH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.